EFPIA - NEWSLETTER

EFPIA Newsletter 04 February 2021

Video | #WeWontRest until we beat cancer

News

03 February 2021 Cancer experts, patients and industry applaud Europe’s Beating Cancer Plan and reemphasise...

The Plan will guide country efforts and includes commitment to shared goals and actions

02 February 2021 EFPIA response to the European Health Union consultations

Strengthening Europe’s capacity to prepare and respond to public health threats

29 January 2021 EFPIA Statement in response to EU Export Restrictions for COVID-19 vaccines

The establishment by the European Commission of an export authorisation system for Member States to use regarding COVID-19...

Blogs

04 February 2021 IMI Impact: Beating cancer – together (Guest blog)

With €190 million invested since 2008, the Innovative Medicines Initiative (IMI) is advancing the fight against cancer...

02 February 2021 Improving cancer literacy in Europe to save time, costs and lives (Guest Blog)

Improved cancer literacy of patients and communication skills of health professionals involved in cancer-related services...

Events

23 FEB 2021

Unlocking the Potential of Precision Medicine in Europe Virtual Event

How to improve cancer care through broader access to quality biomarker testing

Learn more →

15 MAR 2021

DIA Europe 2021 Virtual event

Dedicated to Advancing Healthcare Priorities

Learn more →

We published

Electronic product information: From principles to actions 03 February 2021 (Publications)

AESGP, EFPIA and Medicines for Europe reflections on EMA-HMA–EC Key principles for electronic product information

What we are reading

NEURONET Knowledge Base 04 February 2021 (Neuronet)

This is the time to collaborate for a global victory over Covid 31 January 2021 (The Guardian)

EU pharma boss urges for unity, avoid vaccine trade war 29 January 2021 (Euractiv)

About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 37 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55
Communications@efpia.eu

▶